Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medexus Pharmaceuticals Inc (MDP.TO)

Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medexus Pharmaceuticals Inc 10 King Street East Suite 600 Toronto ON M5C 1C3 CAN

https://www.medexus.com P: 514-762-2626 F: 514-762-2336

Sector:

Medical

Description:

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Medexus products are generally sold in North America to wholesalers, distributors, government agencies, healthcare facilities and specialty pharmacies.

Key Statistics

Overview:

Market Capitalization, $K 90,776
Shares Outstanding, K 32,420
% of Institutional Shareholders 2.66%

Financials:

Annual Sales, $ 108,332 K
Annual Net Income, $ 2,247 K
Last Quarter Sales, $ 24,741 K
Last Quarter Net Income, $ -315 K

Growth:

1-Year Return -29.32%
3-Year Return 48.15%
5-Year Return -64.01%
5-Year Revenue Growth 14.31%

Per-Share Information:

Most Recent Earnings -0.01 on 11/12/25
Next Earnings Date 02/04/26 [--]
Earnings Per Share ttm 0.01
EPS Growth vs. Prev Year -90.43%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 12/19/18

MDP.TO Ratios

Ratio
Price/Earnings ttm 201.79
Price/Earnings forward 4.60
Price/Earnings to Growth N/A
Return-on-Equity % 0.89%
Return-on-Assets % 0.26%
Profit Margin % 2.07%
Debt/Equity 0.00
Price/Sales 0.59
Price/Book 1.25
Book Value/Share 2.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar